Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Rating of "Moderate Buy" by Brokerages
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven research firms that are currently covering the stock, Marketbeat...